Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Advanced Gastric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04768686
What this trial is testing

FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Hanmi Pharmaceutical Company Limited 20
Testing effectiveness (Phase 2)Study completedNCT00382720
What this trial is testing

Docetaxel and Oxaliplatin in Gastric Cancer

Who this might be right for
Stomach Neoplasms
Sanofi 275
Testing effectiveness (Phase 2)UnknownNCT01100801
What this trial is testing

Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients

Who this might be right for
Recurrent Gastric Cancer
National University Hospital, Singapore 90
Testing effectiveness (Phase 2)UnknownNCT04826107
What this trial is testing

Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 196
Testing effectiveness (Phase 2)Study completedNCT01396707
What this trial is testing

Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX

Who this might be right for
Metastatic or Recurrent Gastric AdenocarcinomaHer-2 Positive Gastric Cancer
Asan Medical Center 55
Large-scale testing (Phase 3)UnknownNCT05002686
What this trial is testing

Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis

Who this might be right for
Gastric Cancer
Ruijin Hospital 60
Large-scale testing (Phase 3)UnknownNCT03680261
What this trial is testing

Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy

Who this might be right for
Gastric Cancer
Shanghai Zhongshan Hospital 556
Testing effectiveness (Phase 2)Looking for participantsNCT07149090
What this trial is testing

Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites

Who this might be right for
STOMACH NEOPLASMGastric CancerGastric Cancer Adenocarcinoma Metastatic
Asan Medical Center 61
Testing effectiveness (Phase 2)Looking for participantsNCT06776770
What this trial is testing

A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer

Who this might be right for
Gastric Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 52
Large-scale testing (Phase 3)Active Not RecruitingNCT04950322
What this trial is testing

A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastric or Gastroesophageal Junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 737
Testing effectiveness (Phase 2)UnknownNCT02504229
What this trial is testing

DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment

Who this might be right for
Gastric Cancer
Beijing Biohealthcare Biotechnology Co.,Ltd 80
Not applicableStudy completedNCT02425930
What this trial is testing

The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric CancerComplement Component DeficiencySurgery
First Affiliated Hospital, Sun Yat-Sen University 85
Testing effectiveness (Phase 2)UnknownNCT05095636
What this trial is testing

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Gastric CancerMetastasis
Fudan University 102
Testing effectiveness (Phase 2)Looking for participantsNCT06341595
What this trial is testing

Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM

Who this might be right for
Gastric CancerGastric Cancer Metastatic to Regional Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Not applicableStudy completedNCT05892926
What this trial is testing

HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia

Who this might be right for
Adenocarcinoma
AstraZeneca 204
Testing effectiveness (Phase 2)Looking for participantsNCT07025889
What this trial is testing

IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer

Who this might be right for
Gastric Cancer
Ruijin Hospital 55
Not applicableStudy completedNCT06478368
What this trial is testing

Prediction of Occult Peritoneal Metastasis of Locally Advanced Gastric Cancer Using Multimodal Data Based on Artificial Intelligence Combined With Intraoperative Dynamic Video

Who this might be right for
This Study Uses AI and Multimodal Data to Noninvasively Detect Occult Peritoneal Metastasis
Qun Zhao 1,000
Early research (Phase 1)Enrolling By InvitationNCT07218003
What this trial is testing

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Who this might be right for
Non Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more
Rondo Therapeutics 149
Large-scale testing (Phase 3)Study completedNCT02563054
What this trial is testing

Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 316
Next Page